Drug intelligence / Profile preview

Mouse allergenic extract

Development stage
Phase 2
Modality
Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intradermal, Epicutaneous
01

Overview

Mouse allergenic extracts are biologic preparations derived from natural sources such as mouse epithelium or urine. They are used for the diagnosis and treatment (immunotherapy) of allergic diseases caused by exposure to mice, including allergic rhinitis and asthma. The mechanism of action involves the induction of an immune response; diagnostically, they provoke a reaction in sensitized individuals via IgE-mediated histamine release from mast cells. For immunotherapy, repeated administration leads to increased production of IgG antibodies and regulatory T cell responses that suppress allergic reactions over time. Mouse epithelial extracts typically contain a mixture of proteins including albumin and small amounts of the major mouse allergen Mus m 1, while urine-derived extracts may have higher concentrations of Mus m 1[1][4][8]. These products are not standardized in the US and their composition can vary depending on source material and manufacturing process[6][8].

Other names
mouse epithelial extractmouse urine allergen extractMus m 1 allergen extract
02

Targets

IgE (Immunoglobulin E)

Beyond the preview

Go deeper on Mouse allergenic extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mouse allergenic extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call